Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study

AIMS: Rapid-cycling bipolar disorder is difficult to treat and associated with greater morbidity than non-rapid-cycling disease. This post hoc analysis evaluated 28 patients with rapid-cycling bipolar I disorder from a 100-week, double-blind, placebo-controlled study assessing long-term efficacy, sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Muzina, D J, Momah, C, Eudicone, J M, Pikalov, A, McQuade, R D, Marcus, R N, Sanchez, R, Carlson, B X
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2324208/
https://www.ncbi.nlm.nih.gov/pubmed/18373615
http://dx.doi.org/10.1111/j.1742-1241.2008.01735.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2324208/
https://www.ncbi.nlm.nih.gov/pubmed/18373615
http://dx.doi.org/10.1111/j.1742-1241.2008.01735.x

Ejemplares similares